Stucki G
Department of Rheumatology, University Hospital, Zürich, Switzerland.
Baillieres Clin Rheumatol. 1997 Feb;11(1):97-107. doi: 10.1016/s0950-3579(97)80035-0.
In increasingly cost-conscious, accountable and integrated health-care systems, the appropriate role of speciality care is under scrutiny. The data on the impact of rheumatologist care on outcomes in patients with rheumatoid arthritis (RA) is limited and inconclusive. However, based on a review of processes of care known to be related to superior patient outcomes it is suggested that rheumatologists should be the lead physicians in patients with RA. Rheumatologists but usually not generalists have the experience necessary to make an early diagnosis and to initiate appropriate disease modifying anti-rheumatic drug (DMARD) treatment. Rheumatologists have an in-depth understanding of new assessment methods to optimize medical treatment and to make best use of and co-ordinate multi-disciplinary care. To avoid delay of diagnosis and initiation of treatment, patients with polyarthritis should be referred to rheumatologists as soon as possible. This requires that access to rheumatologist care is guaranteed.
在成本意识日益增强、强调问责制且相互整合的医疗保健系统中,专科护理的恰当作用正受到审视。关于风湿病学家护理对类风湿关节炎(RA)患者治疗结果影响的数据有限且尚无定论。然而,基于对已知与卓越患者治疗结果相关的护理流程的审查,有人建议风湿病学家应成为RA患者的主治医生。风湿病学家而非全科医生具备进行早期诊断和启动适当的改善病情抗风湿药物(DMARD)治疗所需的经验。风湿病学家对优化药物治疗以及充分利用和协调多学科护理的新评估方法有深入了解。为避免诊断和治疗延误,多关节炎患者应尽快转诊至风湿病学家处。这需要确保能够获得风湿病学家的护理。